Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors

Background: Cardiovascular adverse events (CV-AEs) are considered critical complications in chronic myeloid leukemia (CML) patients treated with second- and third-generation tyrosine kinase inhibitors (TKIs). The aim of our study was to assess the correlation between metabolic profiles and CV-AEs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Caocci, Giovanni, Deidda, Martino, Noto, Antonio, Greco, Marianna, Simula, Maria Pina, Mulas, Olga, Cocco, Daniele, Fattuoni, Claudia, Mercuro, Giuseppe, La Nasa, Giorgio, Cadeddu Dessalvi, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231160/
https://www.ncbi.nlm.nih.gov/pubmed/32326001
http://dx.doi.org/10.3390/jcm9041180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231160/
https://www.ncbi.nlm.nih.gov/pubmed/32326001
http://dx.doi.org/10.3390/jcm9041180

Ejemplares similares